ArticleCureus2025
Kasabach-Merritt Phenomenon of the Parotid Gland: Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kasabach-Merritt phenomenon (KMP) is a rare but life-threatening condition characterized by consumptive coagulopathy associated with a vascular tumor. This phenomenon usually presents in early infancy and commonly reported sites of tumor include extremities, trunk, and neck. We report a newborn with KMP, presenting with parotid gland hemangioma and associated vascular complications. This case report and literature review, aim to describe the imaging features of KMP in an infant, along with a compilation of cases from the literature, with a particular focus on the radiological findings of the vascular tumor. Sixteen patients described in seven articles published between 1993 and 2021 were analyzed. Most of the cases were males (56%), with a median age of 13.5 days, an interquartile range (IQR) of 2.75 to 30 days, and lesions primarily located in the parotid gland. The most commonly affected side was 87.5% of cases involved the main gland, 6.25% the thoracic wall and 6.25 the supraclavicular region. The lesions also involved secondary sites such as the temporal region, submandibular area, neck, facial region, and extensive areas involving the thorax and extremities. KMP in the parotid gland is a rare manifestation. Advanced radiological imaging, particularly MRI and contrast-enhanced CT, plays a critical role in the diagnosis, staging, and detection of associated complications. The integration of imaging findings with clinical and laboratory data is essential for timely therapeutic decisions. Continued efforts to refine imaging protocols and gather epidemiological data will improve the prognosis of patients with this complex condition, emphasizing the need for a multidisciplinary approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.